4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine has been researched along with piperidines in 1 studies
Studies (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Trials (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Recent Studies (post-2010) (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Studies (piperidines) | Trials (piperidines) | Recent Studies (post-2010) (piperidines) |
---|---|---|---|---|---|
42 | 0 | 9 | 40,235 | 5,221 | 14,545 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertrand, M; Charlot, V; Dekeyne, A; Despaux, N; Genissel, P; Giraud, H; Goument, B; Millan, MJ; Newman-Tancredi, A; Nisole, C; Peglion, JL | 1 |
1 other study(ies) available for 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and piperidines
Article | Year |
---|---|
Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols.
Topics: Animals; Anti-Anxiety Agents; Biological Availability; Caco-2 Cells; Cerebral Cortex; CHO Cells; Cricetinae; Hepatocytes; Humans; Hypothermia, Induced; In Vitro Techniques; Indans; Intestinal Absorption; Ligands; Male; Microsomes, Liver; Piperazines; Piperidines; Pyridines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Social Behavior; Structure-Activity Relationship; Vocalization, Animal | 2002 |